What is NDC 57237-156?

57237-156 is the product NDC for Moxifloxacin Hydrochloride, Moxifloxacin hydrochloride 400 mg/1 tablet, film coated, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Rising Pharma Holdings, Inc., NDC labeler code 57237. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Moxifloxacin Hydrochloride?

19 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Moxifloxacin Hydrochloride NDC 57237-156

NDC codes

FDA NDC Directory

Product NDC (as listed)57237-156Labeler and product segments. Claims need a package NDC.

Product NDC at billing width57237-0156Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
57237-156-30	5723701563057237015630	30 TABLET, FILM COATED in 1 BOTTLE (57237-156-30)Marketed from Mar 4, 2014

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Moxifloxacin Hydrochloride
Generic name (nonproprietary): moxifloxacin hydrochloride
Active ingredients: Moxifloxacin hydrochloride — 400 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Rising Pharma Holdings, Inc.NDC labeler code 57237
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202632
Marketing start: Mar 4, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Fluoroquinolones (Chemical structure)
Identifiers: Product ID 57237-156_20ac52fe-93eb-47c8-8bab-37f745f795fbSPL ID 20ac52fe-93eb-47c8-8bab-37f745f795fbSPL set ID f34c08e6-fe74-4de3-9e36-a82c3c1c183bRxCUI 311787UNII C53598599TUPC 0357237156308
Pharmacologic class: Fluoroquinolone Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N457237015630 followed by a unit qualifier and the quantity

Package 57237-0156-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 10, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Moxifloxacin tablets are a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria, in the conditions listed below: Community Acquired Pneumonia ( 1.1 ) Skin and Skin Structure Infections: Uncomplicated (1.2) and Complicated ( 1.3 ) Complicated Intra-Abdominal Infections ( 1.4 ) Plague ( 1.5 ) Acute Bacterial Sinusitis ( 1.6 ) Acute Bacterial Exacerbation of Chronic Bronchitis ( 1.7 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of moxifloxacin tablets and other antibacterial drugs. Moxifloxacin tablets should be used only to treat or prevent infections that are proven…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 57237-156

What is NDC 57237-156?: 57237-156 is the product NDC for Moxifloxacin Hydrochloride, Moxifloxacin hydrochloride 400 mg/1 tablet, film coated, listed with the FDA by Rising Pharma Holdings, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Moxifloxacin Hydrochloride.
What is the active ingredient?: Moxifloxacin hydrochloride.
Who is the labeler?: Rising Pharma Holdings, Inc., NDC labeler code 57237. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Moxifloxacin Hydrochloride?: 19 other product NDCs are listed under this name. See all Moxifloxacin Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Moxifloxacin Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4458	70518-4458-00
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 5 mg/mL	Solution/ dropsOphthalmic	Redpharm Drug	67296-2232	67296-2232-03
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 5 mg/mL	Solution/ dropsOphthalmic	Somerset Therapeutics, LLC	70069-081	70069-0081-01
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7407	00904-7407-0400904-7407-06
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-3738	70518-3738-00
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 5 mg/mL	SolutionOphthalmic	Upsher-Smith Laboratories, LLC	0832-1410	00832-1410-03
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 5 mg/mL	SolutionOphthalmic	Asclemed USA, Inc.	76420-331	76420-0331-03
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/250mL	Injection, SolutionIntravenous	Mylan Institutional LLC	67457-323	67457-0323-25
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	AvPAK	50268-576	50268-0576-13
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	American Health Packaging	68084-722	68084-0722-65

All 20 Moxifloxacin Hydrochloride NDCs

Other NDCs under ANDA 202632

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202632
Product	Strength	Form · route	Labeler	Product NDC
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7407
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-6609
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7244
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	A-S Medication Solutions	50090-7665
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	AvPAK	50268-576
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-603
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	American Health Packaging	68084-722
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-3738
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4458
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2329
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-2815
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	72789-037
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	72789-038
Moxifloxacin Hydrochloride	Moxifloxacin hydrochloride 400 mg/1	Tablet, Film coatedOral	PD-Rx Pharmaceuticals, Inc.	72789-350